Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 5.30
-0.36 (-6.36%)
Aug 4, 2026, 4:27 PM CET
Thor Medical ASA Market Cap
Thor Medical ASA has a market cap or net worth of 1.91 billion as of August 4, 2026. Its market cap has increased by 116.65% in one year.
Market Cap
1.91B
Enterprise Value
1.90B
Revenue
839.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
5.30
ChartMarket Cap Chart
Since July 4, 2023, Thor Medical ASA's market cap has increased from 466.61M to 1.91B, an increase of 308.91%. That is a compound annual growth rate of 57.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.91B | 2.64% |
| Dec 30, 2025 | 1.86B | 151.99% |
| Dec 30, 2024 | 737.69M | 144.87% |
| Dec 29, 2023 | 301.27M | -35.44% |
| Jul 4, 2023 | 466.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 1.96B |
| Nykode Therapeutics AS | 1.09B |
| ArcticZymes Technologies ASA | 995.89M |
| Zelluna ASA | 664.75M |
| Lytix Biopharma ASA | 653.65M |
| Oncoinvent ASA | 362.75M |
| SoftOx Solutions AS | 231.56M |
| Arctic Bioscience AS | 80.87M |